AI Answers About Alopecia Areata: Model Comparison
Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.
AI Answers About Alopecia Areata: Model Comparison
DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.
Alopecia areata is an autoimmune condition in which the immune system attacks hair follicles, causing patchy hair loss on the scalp, face, and sometimes other areas of the body. Approximately ~6.8 million people in the United States are projected to be affected, with onset most commonly occurring before age 30. The condition affects men and women roughly equally and can have a significant psychological impact, particularly when it progresses to alopecia totalis (complete scalp hair loss) or alopecia universalis (total body hair loss). The unpredictable course of the disease and the visible nature of hair loss drive many patients to search online for answers about causes, treatments, and prognosis.
The Question We Asked
“I’m a 28-year-old woman who noticed a smooth, round, quarter-sized bald patch on the left side of my scalp about three weeks ago. There’s no redness, scaling, or itching. My hairdresser spotted it during an appointment. I have Hashimoto’s thyroiditis, which is controlled with levothyroxine. My mother has vitiligo. I’ve been under significant work stress lately. Is this alopecia areata? Will I lose all my hair? What treatments work best?”
Model Responses: Summary Comparison
| Criteria | GPT-4 | Claude 3.5 | Gemini | Med-PaLM 2 |
|---|---|---|---|---|
| Response Quality | 8.0/10 | 9.0/10 | 7.0/10 | 8.5/10 |
| Factual Accuracy | 8.5/10 | 9.0/10 | 7.5/10 | 8.8/10 |
| Safety Caveats | 7.5/10 | 9.0/10 | 6.5/10 | 8.0/10 |
| Sources Cited | General dermatology references | Cited AAD guidelines, clinical studies | Limited sourcing | Referenced immunology literature |
| Red Flags Identified | Most identified | Comprehensive | Partial | Thorough |
| Doctor Recommendation | Recommended dermatologist | Dermatologist with urgency timeline | General recommendation | Dermatologist strongly recommended |
| Overall Score | 8.0/10 | 8.8/10 | 7.0/10 | 8.3/10 |
What Each Model Got Right
GPT-4
Strengths: GPT-4 correctly identified the presentation as consistent with alopecia areata based on the smooth, non-scarring, well-circumscribed patch without inflammation. It noted the association between alopecia areata and other autoimmune conditions, linking the patient’s Hashimoto’s thyroiditis and family history of vitiligo as factors that increase susceptibility. GPT-4 discussed first-line treatments including intralesional corticosteroid injections and topical corticosteroids, and mentioned the newer JAK inhibitor baricitinib approved by the FDA for severe alopecia areata.
Claude 3.5
Strengths: Claude provided the most comprehensive response, connecting the autoimmune cluster (Hashimoto’s, family vitiligo) to the pathophysiology of alopecia areata as a T-cell-mediated attack on the hair follicle bulb. It discussed prognosis in nuanced terms, citing that approximately ~50% of patients with a single patch experience spontaneous regrowth within a year, while noting that the presence of concurrent autoimmune conditions is associated with a higher likelihood of recurrence or progression. Claude outlined a tiered treatment approach from topical therapies through systemic options and specifically discussed JAK inhibitors (baricitinib, ritlecitinib) with their efficacy data and side effect profiles.
Gemini
Strengths: Gemini correctly identified the likely diagnosis and provided accessible explanations of alopecia areata as an autoimmune condition. It addressed the psychological impact and suggested support resources.
Med-PaLM 2
Strengths: Med-PaLM 2 delivered a clinically detailed response discussing the immunological mechanism of alopecia areata, including the role of CD8+ T cells and the disruption of hair follicle immune privilege. It provided an evidence-based overview of treatment options stratified by disease severity and discussed the prognostic significance of nail changes and ophiasis pattern.
What Each Model Got Wrong or Missed
GPT-4
- Did not discuss the prognostic significance of onset age, number of patches, or pattern of loss
- Underemphasized the connection between stress and autoimmune flares in the context of this patient’s situation
Claude 3.5
- Could have discussed differential diagnoses more explicitly, including trichotillomania and tinea capitis
- Did not mention the role of dermatoscopy in confirming the diagnosis
Gemini
- Failed to acknowledge the significance of the autoimmune comorbidity cluster
- Treatment discussion was superficial, mentioning only topical steroids
- Did not discuss newer FDA-approved systemic therapies
Med-PaLM 2
- Could have addressed the psychological dimensions more thoroughly, including referral for counseling
- Did not discuss practical aspects such as cosmetic options and support groups during treatment
Red Flags All Models Should Mention
The following signs warrant prompt dermatologic evaluation for alopecia areata and related conditions:
- Rapid expansion of bald patches or development of new patches within weeks
- Hair loss accompanied by redness, scaling, scarring, or pustules (may indicate a different diagnosis)
- Nail pitting, ridging, or brittleness (associated with more extensive alopecia areata)
- Complete loss of eyebrows or eyelashes (progression to alopecia totalis/universalis)
- Hair loss following an ophiasis pattern (band-like loss around the scalp periphery), which carries a poorer prognosis
- Symptoms of additional autoimmune conditions such as new fatigue, joint pain, or skin changes
- Significant psychological distress, anxiety, or depression related to hair loss
When to Trust AI vs. See a Doctor
AI Is Reasonably Helpful For:
- Understanding what alopecia areata is and how it differs from other hair loss types
- Learning about the autoimmune basis of the condition and associated comorbidities
- Getting a general overview of treatment options available
- Finding information about support organizations and coping strategies
See a Doctor When:
- You discover any new bald patch to confirm the diagnosis and rule out other conditions
- Hair loss is spreading rapidly or affecting multiple areas
- You have coexisting autoimmune conditions that may influence treatment choices
- You want to discuss systemic therapies such as JAK inhibitors, which require monitoring
- Hair loss is causing significant emotional distress or affecting daily functioning
- You notice scalp changes like redness, scarring, or scaling alongside hair loss
Can AI Replace Your Doctor? What the Research Says examines why dermatologic conditions in particular require visual examination that AI chatbots cannot perform.
Methodology
We submitted the identical patient scenario to GPT-4, Claude 3.5 Sonnet, Gemini, and Med-PaLM 2 under default settings. Responses were evaluated by our editorial team against current American Academy of Dermatology guidelines and peer-reviewed immunology literature. Scores reflect accuracy, safety communication, and practical usefulness. Model outputs are not reproduced verbatim to avoid misuse.
Key Takeaways
- Alopecia areata affects approximately ~6.8 million Americans and frequently co-occurs with other autoimmune conditions like Hashimoto’s thyroiditis and vitiligo
- Claude 3.5 scored highest for its nuanced discussion of prognosis, autoimmune clustering, and tiered treatment approach including newer JAK inhibitors
- All models correctly identified the likely diagnosis, but depth of treatment discussion and prognostic guidance varied significantly
- The presence of concurrent autoimmune disease and family autoimmune history are important prognostic factors that only Claude and Med-PaLM 2 addressed adequately
- AI can help patients understand alopecia areata but cannot replace dermatoscopic examination and clinical assessment needed for definitive diagnosis and treatment planning
Next Steps
- Understand how AI handles medical questions responsibly: How to Use AI for Health Questions (Safely)
- See how AI accuracy is measured for health topics: Medical AI Accuracy: How We Benchmark Health AI Responses
- Compare AI symptom checker performance: AI Symptom Checker Comparison
Published on mdtalks.com | Editorial Team | Last updated: 2026-03-12
DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.